Rijke consumenten kopen nieuwe garderobe door afslankpillen en stutten luxesector

Affluent consumers using GLP-1 weight-loss drugs are driving unexpected growth in luxury retail by purchasing new wardrobes and upgrading their dining experiences, offsetting challenges from geopolitical tensions that have reduced spending in key markets. This trend reflects how pharmaceutical innovations are reshaping consumer behavior in the premium sector.